What is Ensysce Biosciences Inc?
, a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.00M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.